SCHEMBL1534488

SCHEMBL1534488

COc1c(C#CC(=O)c2ccccc2)ccnc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.44
NTSR1 P30989 1/20 0.44
VCP P55072 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPC1 O15118 2/20 0.36
ALDH1A1 P00352 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
FFAR1 O14842 2/20 0.35
APP P05067 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
S1PR2 O95136 1/20 0.33
MAPT P10636 1/20 0.33
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534560 0.85 HSP90AA1 (0.46) HSP90AA1NTSR1VCPCYP1A2NPC1
SCHEMBL1534616 0.75 HSP90AA1 (0.49) HSP90AA1NTSR1VCPCYP1A2CYP2C19
SCHEMBL1534485 0.75 HSP90AA1 (0.53) HSP90AA1NTSR1VCPCYP1A2NPC1
SCHEMBL1534678 0.74 HSP90AA1 (0.51) HSP90AA1NTSR1VCPCYP1A2CYP2C19
SCHEMBL1534391 0.74 HSP90AA1 (0.51) HSP90AA1NTSR1VCPNPC1ALDH1A1
SCHEMBL1534465 0.74 HSP90AA1 (0.51) HSP90AA1NTSR1VCPALDH1A1RAB9A
SCHEMBL1534333 0.72 HSP90AA1 (0.46) HSP90AA1NTSR1VCPCYP1A2CYP2C19
SCHEMBL15758850 0.72 L3MBTL1 (0.38) CYP1A2CYP2C9CYP2C19ALDH1A1RAB9A
SCHEMBL27167227 0.71 HSP90AA1 (0.63) HSP90AA1NTSR1VCPNPC1ALDH1A1
SCHEMBL1534632 0.70 ALDH1A1 (0.46) HSP90AA1NTSR1VCPNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR HSP90AA1 1265/4885NTSR1 4367/4885VCP 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.